BiotechTube

Beriplex

Phase 2UNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 31/100
31
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Action Reversal

Conditions

Drug Action Reversal

Trial Timeline

Jan 1, 2015 → Dec 1, 2016

NCT ID
NCT02463591

About Beriplex

Beriplex is a phase 2 stage product being developed by CSL for Drug Action Reversal. The current trial status is unknown. This product is registered under clinical trial identifier NCT02463591. Target conditions include Drug Action Reversal.

What happened to similar drugs?

8 of 15 similar drugs in Drug Action Reversal were approved

Approved (8) Terminated (3) Active (5)
✅CefiderocolShionogiApproved
✅OnabotulinumtoxinA 145 UNT [Botox]AbbVieApproved
✅Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mLNovartisApproved
✅Oseltamivir + WarfarinRocheApproved
✅Rivaroxaban 20mg + Sotorasib 960mgAmgenApproved
✅Polyene phosphatidylcholine injection 930 mg QD + Magnesium Isoglycyrrhizinate injection 200 mg QDHaisco Pharmaceutical GroupApproved
✅AZILECT® + PlaceboLundbeckApproved

Hype Score Breakdown

Clinical
12
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02463591Phase 2UNKNOWN

Competing Products

20 competing products in Drug Action Reversal

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
32
GP404141 + NplateGEROPHARMPhase 3
34
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
29
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
29
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
29
DS-1040b + ClopidogrelDaiichi SankyoPhase 1
29
EC905 + verapamilAstellas PharmaPhase 1
29
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
29
enzalutamide + rifampinAstellas PharmaPhase 1
29
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
29
CefiderocolShionogiApproved
50
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
29
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
29
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
29
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
40
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
29
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
29
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
29
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit JuiceJohnson & JohnsonPhase 1
29
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
40